CLOT DRUG EYED IN 235 DEATHS: FDA

- NY Post

11/18/2007 - The Food and Drug Administration has tallied at least 235 reports of deaths linked to the blood-clotting drug Trasylol, officials told The Post.

The FDA received 235 reports "that noted death in patients who received Trasylol" to control bleeding during heart-bypass surgery from 1993, when the drug was approved, through February 2006, said agency spokeswoman Peper Long.

The reports - from doctors, health-care providers and relatives - do not necessarily prove Trasylol killed the patients, Long said.

She could not give the number of deaths over the past 19 months - when such reports were expected to jump following several studies warning the drug could cause kidney damage, stroke and heart failure.

The FDA this month finally asked Bayer AG to stop selling the lucrative drug pending further review.

The agency acted after Canada halted a clinical study when early results found Trasylol might raise the risk of death 50 percent over other drugs.

The Post last month reported the August 2006 death of Trasylol patient Joseph Randone, 52, a Long Island travel agent and dad, after an eight-month hospitalization that included kidney dialysis and amputation of his legs. His doctor filed a report with the FDA.

Ennis & Ennis, P.A. is representing individuals that have been harmed as a result of Trasylol side effects. If you or a loved one have suffered as a result of Trasylol side effects such as kidney failure, heart attack, or stroke you may be entitled to compensation. For more information about a Trasylol lawsuit, a possible Trasylol recall, or for questions regarding Trasylol class action lawsuits click here for a free, confidential case evaluation.